Travere Names Bradley Campbell Chief Executive Officer

Company: Travere Therapeutics · Event Type: CEO Succession · New CXO: Bradley L. Campbell (President, CEO and Director) · Context: Eric Dube steps down December 1, 2026, citing health and family; serves as executive advisor through February 15, 2027 · Date: September 21, 2026 Summary…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Tags
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *

Saturday Rounds

Genentech / Astex | Breast Cancer Discovery Collaboration Amid gRED Restructuring
Sobi Licenses Lacutamab in $580 Million Deal
Moonwalk Raises $70 Million for Adipose-Targeted RNAi
Neomorph – $100M Molecular Glue Financing